Ed joined Sygnature Discovery in October 2016 and has over 15 years of experience in the pharmaceutical industry, covering both GLP and non-regulated environments. He worked in a GLP setting for 4 years; firstly with GlaxoSmithKline (GSK) and then Simbec Research in South Wales. Following this he joined GSK’s Neural Pathways Discovery Performance Unit (DPU) in Singapore where he remained for 11 years. Responsible for establishing the DPU’s DMPK group he oversaw the development of in-vitro, in-vivo and bioanalytical labs and supported discovery projects across a range of CNS targets. Ed was also a member of the sites leadership team and held advisory positions supporting discovery research in GSK’s R&D China unit. He has a BSc (Hons) in Chemistry and a PhD in Mass Spectrometry both from the University of Wales, Swansea (now Swansea University).